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        NK cells are innate immune eff  ector cells that 
secrete cytokines and acquire cytolytic func-
tion within hours of viral infections. The acti-
vation of NK cells is regulated by the balance 
of inhibitory and activating signals and is de-
pendent on DCs, cytokines, and co-stimulatory 
molecules (  1  –  3  ). NK cell responses to micro-
bes are triggered by Toll-like receptor (TLR) 
ligands, which stimulate secretion of type I 
IFNs that in turn support IL-15 and IL-15R     
production (  4  –  6  ). 
  IL-15 and its proprietary receptor IL-15R     
are both essential for supporting NK cell ho-
meostasis (  7  ). An unusual aspect of IL-15 and 
IL-15R     binding is the extraordinarily high af-
fi  nity with which these proteins interact (    5   ×   
10      11   M) (  8, 9  ). Another notable observation is 
that the phenotypes of IL-15 (IL-15      /     ) and 
IL-15R     (IL-15R          /     )   –  defi   cient mice are 
indistinguishable, suggesting that physiologi-
cally relevant IL-15 signals require IL-15R     
and that these molecules function in close co-
operation (  10, 11  ). On the other hand, some 
studies have reported secretion of soluble IL-
15, and the ability of recombinant IL-15 to 
stimulate cells bearing IL-2/15R     and     c but 
lacking IL-15R    raises questions about whether 
and when IL-15 may perform IL-15R      –  inde-
pendent functions. Additional questions sur-
rounding IL-15 and IL-15R     biology relate 
to the observations that IL-15 cDNAs are diffi   -
cult to express heterologously unless leader se-
quences, ATG sites, and 3     mRNA sequences 
are altered (  12  ). These fi  ndings suggest that com-
plex intracellular processing regulates the bio-
availability of IL-15. 
  Prior studies from our laboratory showed 
that IL-15R     functions in an unexpected non  –
  cell-autonomous fashion in vivo (  13  –  15  ). IL-
15R     expression on responding cells does not 
enhance the responsiveness of IL-15  –  depen-
dent cells in vivo (  13  –  16  ). Soluble IL-15 can 
bind to IL-15R     on accessory cells that   “  trans 
present  ”   IL-15 to responding cells in vitro (  17  ). 
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  Natural killer (NK) cells are innate immune effectors that mediate rapid responses to viral 
antigens. Interleukin (IL)-15 and its high affi  nity IL-15 receptor, IL-15R    , support NK cell 
homeostasis in resting animals via a novel trans presentation mechanism. To better under-
stand how IL-15 and IL-15R     support NK cell activation during immune responses, we 
have used sensitive assays for detecting native IL-15 and IL-15R     proteins and developed 
an assay for detecting complexes of these proteins. We fi  nd that IL-15 and IL-15R     are 
preassembled in complexes within the endoplasmic reticulum/Golgi of stimulated dendritic 
cells (DCs) before being released from cells. IL-15R     is required for IL-15 production by 
DCs, and IL-15 that emerges onto the cell surface of matured DCs does not bind to neigh-
boring cells expressing IL-15R    . We also fi  nd that soluble IL-15  –  IL-15R     complexes are 
induced during infl  ammation, but membrane-bound IL-15  –  IL-15R     complexes, rather than 
soluble complexes, support NK cell activation in vitro and in vivo. Finally, we provide in vivo 
evidence that expression of IL-15R     specifi  cally on DCs is critical for trans presenting 
IL-15 and activating NK cells. These studies defi  ne an unprecedented cytokine  –  receptor 
biosynthetic pathway in which IL-15R     serves as a chaperone for IL-15, after which mem-
brane-bound IL-15R      –  IL-15 complexes activate NK cells via direct cell  –  cell contact. 1214 IL-15R     CHAPERONES IL-15 TO DENDRITIC CELL MEMBRANES | Mortier et al.
Negligible levels of IL-15R     were detected in cell lysates 
from nonstimulated bone marrow  –  derived DCs (BMDCs), 
and IL-15R     protein levels were similarly induced in lysates 
from WT or   IL-15       /         cell BMDCs (but not   IL-15R            /         
cells) between 2 and 12 h (  Fig. 1 A  ).   Hence, IL-15R     is 
  induced in DCs by TLR stimulation, and IL-15 does not 
  infl  uence the production of IL-15R    . 
  Somewhat surprisingly, IL-15 protein was only transiently 
detected at modest levels within   IL-15R            /         BMDCs and 
not at all in WT cells (  Fig. 1 B  ). This occurred despite the fact 
that IL-15 mRNA levels, detected by real-time PCR, were 
markedly induced by poly I:C in both   IL-15R            /         and WT 
BMDCs (unpublished data). To understand why IL-15 pro-
tein was not detected in WT cells, we hypothesized that IL-15 
in WT cells might be complexed with IL-15R     protein. As 
noted above, epitopes of IL-15 detected by several anti  –  IL-15 
antibodies are blocked by high affi   nity interactions between 
IL-15 and IL-15R    . To investigate whether IL-15 is com-
plexed with IL-15R     in poly I:C  –  stimulated BMDCs, we 
established conditions to dissociate these proteins without de-
naturing them before ELISA analyses. We boiled lysates from 
poly I:C  –  stimulated BMDCs in the presence of 0.01% SDS 
before analyzing IL-15 protein levels by ELISA. These exper-
iments showed that IL-15 protein was indeed induced in WT 
cells at nanomolar levels in parallel with the induction of IL-
15R     (  Fig. 1 C  ). Similar results were obtained with LPS stim-
ulation of DCs (unpublished data). Thus, IL-15 is induced by 
TLR stimulation and appears to be predominantly bound to 
another protein (e.g., IL-15R    ) inside DCs. 
  To further examine the possibility that endogenous IL-15 
and IL-15R     proteins exist in complexes in normal BMDCs, 
we developed a   “  complex  ”   ELISA in which an anti  –  IL-15 
antibody that detects IL-15 in the presence of IL-15R     was 
Trans presentation in vivo requires expression of IL-15 and 
IL-15R     by hematopoietic accessory cells and expression of 
IL-2/15R     by IL-15  –  responsive NK cells and memory 
CD8  +   T cells (  18  ). Trans presentation appears to be the dom-
inant mechanism by which IL-15 signals are delivered in vivo 
(  13  –  16, 18  ). 
  Why IL-15 signals should be delivered via this somewhat 
complicated trans presentation mechanism is unclear. Some 
clues have been provided by recent studies revealing that co-
ordinate expression of IL-15 and IL-15R     by the same ac-
cessory cells such as DCs is required for supporting both NK 
and CD8  +   memory T cell homeostasis (  18, 19  ). These results 
are not consistent with a mechanism in which IL-15 is se-
creted by DCs and subsequently bound to IL-15R     on the 
surface of other DCs to be trans presented to IL-15  –  respon-
sive cells. Instead, they suggest a more complicated model of 
trans presentation. 
  The studies above focused on the functions of IL-15 and 
IL-15R     during noninfl  amed, homeostatic conditions. TLRs 
induce the production of both IL-15 and IL-15R     by mye-
loid cells (  4  –  6, 20  –  22  ). Hence, to understand how endogenous 
IL-15 and IL-15R     proteins function during infl  ammatory 
responses, we have developed sensitive assays for detecting 
endogenous IL-15 and IL-15R     proteins. We have used these 
assays to further examine how these proteins are induced in 
DCs and how they support NK cell activation. 
    RESULTS   
  IL-15, IL-15R    , and complexes of IL-15  –  IL-15R     proteins 
are induced in DCs after TLR stimulation 
  Analyses of the biology of IL-15 and IL-15R     have been 
challenging because the potent physiological eff  ects of these 
proteins occur at relatively low levels of expression. To un-
derstand how IL-15 and IL-15R     function under physiological 
circumstances, we fi  rst optimized ELISAs for these proteins 
using recombinant IL-15 and IL-15R     proteins and found 
that we were able to detect picomolar levels of these proteins 
(unpublished data). Because IL-15 and IL-15R     bind to each 
other with high affi   nity and may function as a complex in 
physiological settings, we investigated whether the presence 
of either protein aff  ects the detection of the other. Detection 
of IL-15R     protein was not aff  ected by the presence of IL-
15 (Fig. S1 A, available at http://www.jem.org/cgi/content/
full/jem.20071913/DC1). In contrast, the detection of IL-15 
protein was progressively diminished by the presence of in-
creasing amounts of IL-15R     protein (Fig. S1 B). These re-
sults suggest that at least one of the anti  –  IL-15 antibodies 
used in our capture ELISA binds to an epitope that is masked 
when IL-15 binds to IL-15R    . Several commercially avail-
able antibodies to IL-15 shared this capacity for interference 
with IL-15R     binding (unpublished data). 
  mRNA transcripts for IL-15 and IL-15R     are induced 
by TLR ligands in DCs, but the translation of these proteins 
may not follow mRNA levels. We thus measured the levels 
of IL-15 and IL-15R     proteins before and after stimula-
tion with LPS or poly inosinic  –  polycytidylic acid (poly I:C). 
    Figure 1.         Detection of IL-15 and IL-15R     proteins and IL-15  –  IL-
15R     complex expression in lysates of TLR-stimulated DCs.   ELISA 
measurement of IL-15R     (A) and IL-15 (B) proteins and IL-15  –  IL-15R    
complex (D) expression in lysates of poly I:C  –  stimulated BMDCs at the indi-
cated time points. (C) ELISA determination of IL-15 protein levels after dis-
sociation of IL-15  –  IL-15R     protein complexes with 0.01% SDS and boiling. 
Lines represent data from WT (   ),   IL-15     /       (   ), and   IL-15R       /       (  )  BMDCs. 
All data are representative of at least three separate experiments.     JEM VOL. 205, May 12, 2008 
ARTICLE
1215
WT DCs co-precipitated signifi  cant amounts of IL-15 pro-
tein, confi  rming that IL-15  –  IL-15R     complexes are induced 
in DCs by TLR stimulation (  Fig. 2 B  ). In contrast, immuno-
precipitation of IL-15R     yielded negligible amounts of co-
precipitated IL-15 in resting WT DCs, or LPS-stimulated 
  IL-15       /         DCs and   IL-15R            /         DCs (  Fig. 2 B   and unpub-
lished data). Importantly, IL-15 was not co-precipitated with 
IL-15R     from 1:1 mixtures of LPS-stimulated   IL-15       /         and 
  IL-15R            /         DCs (  Fig. 2 B  ). Therefore, IL-15 and IL-15R     
must be coordinately expressed by the same cells to form IL-15  –
  IL-15R     complexes  —  even under infl  ammatory conditions 
during which both proteins are induced. 
  IL-15  –  IL-15R     complexes are preassembled in DCs 
in the absence of protein secretion 
  IL-15 protein is not effi   ciently produced in   IL-15R            /         cells 
(  Fig. 1 B  ). One mechanism by which IL-15R     could facili-
tate the production of IL-15 would be if IL-15R     directly 
bound newly synthesized IL-15 before being secreted (e.g., 
used as a   “  capture  ”   antibody and an anti  –  IL-15R     antibody 
was used as a   “  detection  ”   reagent (Fig. S1 C). We used this 
complex ELISA to measure the levels of IL-15  –  IL-15R     
complexes in cell lysates from BMDCs. IL-15  –  IL-15R     com-
plexes were induced by poly I:C in WT BMDCs but not in 
  IL-15       /         BMDCs or   IL-15R            /         BMDCs (  Fig. 1 D  ). The 
kinetics of IL-15  –  IL-15R     complex induction was very sim-
ilar to the induction of IL-15 and IL-15R     proteins. Collec-
tively, these studies suggest that IL-15 and IL-15R     proteins 
are induced in BMDCs by TLR ligands and exist largely in 
IL-15  –  IL-15R     complexes. 
  IL-15  –  IL-15R     complexes are not detected unless IL-15 
and IL-15R     are coordinately expressed by the same DCs 
  Exposure of DCs to TLR ligands is thought to stimulate IL-
15 secretion from DCs, after which IL-15 may be subse-
quently bound to IL-15R     on the cell surface of DCs. The 
identifi  cation of IL-15  –  IL-15R     complexes in the lysates of 
stimulated DCs could thus refl  ect this sequence of events. Al-
ternatively, our prior studies suggest that IL-15 and IL-15R     
must be coordinately expressed on the same hematopoietic 
cells to support IL-15  –  dependent NK cells and memory CD8  +   
T cells under homeostatic (non-infl   amed) conditions (  18  ). 
Thus, it is possible that IL-15R     and IL-15 must be coordi-
nately expressed during TLR-induced infl  ammatory condi-
tions as well. To test this hypothesis, we stimulated a 1:1 mixture 
of   IL-15       /         and   IL-15R            /         BMDCs as well as uniform cul-
tures of WT,   IL-15       /        , and   IL-15R            /         BMDCs with poly I:C 
and measured the production of IL-15  –  IL-15R     complexes 
in BMDC lysates by ELISA. As these cells were plated at con-
centrations at which   IL-15       /         and   IL-15R            /         DCs were 
in direct contact, the production of freely soluble IL-15 pro-
tein from   IL-15R            /         DCs should allow binding of IL-15 
to IL-15R     on the surface of neighboring   IL-15       /         DCs and 
potential recycling of these complexes. These experiments re-
vealed that IL-15  –  IL-15R     complexes are detected only in 
cultures of poly I:C  –  stimulated WT BMDCs and not in 1:1 
mixtures of   IL-15       /         and   IL-15R            /         BMDCs (  Fig. 2 A  ).   
IL-15  –  IL-15R     complexes were predictably absent from 
stimulated   IL-15       /         cells and   IL-15R            /         BMDCs (  Fig. 2 A  ). 
Thus, IL-15 may not be secreted from   IL-15R            /         cells. 
Moreover, IL-15 and IL-15R     proteins must be coordinately 
expressed within the same DCs to form IL-15  –  IL-15R     
complexes  —  even after TLR stimulation. 
  To independently confi  rm that IL-15 and IL-15R     pro-
teins must be coordinately expressed to form IL-15  –  IL-15R     
complexes, we developed an immunoblotting assay to detect 
endogenous IL-15 bound to endogenous IL-15R     protein. 
We stimulated cultures of WT,   IL-15       /       ,   IL-15R            /        , or a 
mixture of   IL-15       /         and   IL-15R          /         DCs with LPS, lysed 
cells, immunoprecipitated endogenous IL-15R    , and immuno-
blotted for IL-15. As IL-15 is dissociated from IL-15R     by 
boiling in sample buff  er (containing 1% SDS) before immuno-
blotting with anti  –  IL-15 antibody, this approach to detecting 
IL-15 is not compromised by potential masking of IL-15 epi-
topes by IL-15R    . Immunoprecipitation of IL-15R     from 
    Figure 2.         Intracellular formation of IL-15  –  IL-15R     complexes 
within TLR-stimulated DCs before protein secretion.   (A) ELISA detection 
of  IL-15 – IL-15R    complexes in lysates from poly I:C  –  stimulated BMDCs of 
the indicated genotypes: WT (   ),   IL-15     /       (15KO;     ), and   IL-15R       /      
(R   KO;     ), and a 1:1 mixture of   IL-15     /       with   IL-15R       /       (15KO:R  KO;    ) 
BMDCs. (B) Immunoblotting detection of IL-15R     co-precipitated IL-15 in 
LPS-stimulated BMDCs. Long and short exposures of IL-15  –  specifi  c 
immunoblots are shown above. Note the absence of IL-15 protein in immuno-
precipitates of mixed 15KO:R    KO BMDCs. Immunoblotting of immuno-
precipitates for IL-15R     are shown below as a control (bottom). (C) ELISA 
detection of IL-15  –  IL-15R     complexes in the lysates of untreated WT DCs 
(    ), DCs treated with LPS plus brefeldin A (    ), DCs treated with LPS plus 
cycloheximide (    ), and DCs treated with LPS plus brefeldin A plus cyclohex-
imide (    ) for the indicated periods of time. (D) EndoH sensitivity of IL-15R    
co-precipitated IL-15 from LPS-stimulated DCs. Note the appearance of an 
    12.7-kD band corresponding to unglycosylated IL-15 in EndoH-treated 
WT DCs (arrow), but not in other control lanes. Short (top) and long (bot-
tom) exposures of IL-15 expression are shown in the top panels. Data are 
representative of three separate experiments.    1216 IL-15R     CHAPERONES IL-15 TO DENDRITIC CELL MEMBRANES | Mortier et al.
sIL-15R     proteins in supernatants from poly I:C  –  stimulated 
BMDCs. These experiments revealed that minimal amounts 
of IL-15 were induced by poly I:C stimulation in the super-
natants of WT BMDCs after 24 (Fig. 3 A, gray columns) and 
48 (Fig. 3 A, black columns) h, but not in supernatants from 
  IL-15       /         and   IL-15R            /         cells.   Given the interference of 
IL-15R     with ELISA-mediated detection of IL-15 in cell 
lysates (  Fig. 1 B  ), we suspected that IL-15 might be present 
in IL-15  –  sIL-15R     protein complexes in these supernatants. 
We thus boiled these supernatants in the presence of 0.01% 
SDS before ELISA and found that IL-15 was indeed induced 
and progressively accumulated in the supernatants from WT 
but not   IL-15       /         cells (  Fig. 3 B  ). Thus, IL-15 is secreted 
from WT DCs predominantly in the form of IL-15  –  sIL-
15R     complexes. Importantly, no IL-15 was observed in the 
supernatants from IL-15R          /      DCs, even after boiling of 
the supernatants (  Fig. 3 B  ). Thus, IL-15R     is required for 
the emergence of IL-15 from cells. 
  Our assays of sIL-15R     levels in supernatants from poly I:C  – 
stimulated DCs show that soluble IL-15R     accumulated in 
the supernatants from WT cells and was detected at similar 
levels in the supernatants from   IL-15       /         cells (  Fig. 3 C  ). 
Hence, IL-15 is not required for the production or release of 
sIL-15R    . To directly examine whether coordinate expression 
of IL-15 and IL-15R     was required for producing soluble IL-
15  –  sIL-15R     protein complexes in the supernatants of poly I:C  – 
stimulated DCs, we assayed supernatants of 1:1 mixed cultures 
of   IL-15       /         and   IL-15R            /         DCs for the presence of these 
complexes. These experiments revealed that IL-15  –  sIL-15R     
complexes were detected only in the supernatants of WT cells, 
but not when IL-15 and IL-15R     are produced by sepa-
rate cells (  Fig. 3 D  ). These results all mirror the fi  ndings 
we obtained in the cellular lysates of BMDCs. Thus, the 
within the ER or Golgi) and stabilized IL-15 in a complex. 
To test this possibility, we pretreated BMDCs with brefeldin 
A (which blocks protein traffi   cking through the Golgi) be-
fore stimulation with LPS, and then tested lysates of these 
cells for the presence of IL-15  –  IL-15R     complexes. Signifi  -
cant levels of IL-15  –  IL-15R     complexes were induced in 
WT cells even in the presence of brefeldin A (  Fig. 2 C  ). No 
IL-15R     protein was observed on the surface of these cells 
by fl  ow cytometry, and no soluble IL-15R     (sIL-15R    ) was 
detected in supernatants, confi  rming that brefeldin A blocked 
the emergence of IL-15R     from the Golgi complex (Fig. S2, 
A and B, available at http://www.jem.org/cgi/content/full/
jem.20071913/DC1). Thus, IL-15R     appears to bind IL-15 
during biogenesis. Brefeldin A may also block the traffi   cking 
of proteins from recycling and/or late endosomes to the plasma 
membrane. To eliminate the possibility that brefeldin A ex-
clusively unveiled recycling complexes in these experiments, 
we treated DCs with LPS plus cycloheximide, which should 
block the formation of nascent IL-15  –  IL-15R     complexes 
but should not block recycling complexes, and then asked 
whether IL-15  –  IL-15R     complexes were induced. These 
experiments revealed that cycloheximide prevented the for-
mation of IL-15  –  IL-15R     complexes, suggesting that the 
complexes we detect in LPS plus brefeldin A  –  treated DCs are 
newly synthesized (  Fig. 2 C  ). 
  Like many transmembrane and secreted proteins, IL-15 
undergoes N-linked glycosylation in the ER, a form that is 
sensitive to EndoH digestion (  23  ). N-linked sugars are re-
moved from IL-15 in the Golgi during further processing so 
that mature forms of IL-15 are resistant to EndoH. To deter-
mine whether IL-15  –  IL-15R     complexes may be assembled 
when IL-15 bears EndoH-sensitive N-linked sugars during 
biogenesis, we asked whether IL-15 that co-precipitated with 
IL-15R     from LPS-stimulated DCs is EndoH sensitive. LPS-
stimulated DCs were lysed in NP-40 lysis buff  er, immuno-
precipitated with anti  –  IL-15R     antibodies, and treated with 
either EndoH or buff  er alone before immunoblotting analysis 
for IL-15 expression. These experiments revealed that EndoH 
treatment of anti  –  IL-15R      –  immunoprecipitated lysates pro-
duces a novel IL-15  –  specifi  c band at     12.7 kD, corresponding 
to un-glycosylated IL-15 (  Fig. 2 D  ). Therefore, native IL-15  –
  IL-15R     complexes contain EndoH-sensitive IL-15, indicat-
ing that these complexes form in the ER or early Golgi before 
the completion of Golgi processing. 
  TLR-stimulated DCs release soluble IL-15  –  sIL-15R     
protein complexes 
  To follow the fate of IL-15  –  IL-15R     complexes after Golgi 
processing, we studied the expression of these proteins on 
the cell surface of stimulated DCs. Emergence of IL-15R     
protein onto the surface of DCs occurs normally in the ab-
sence of IL-15, but emergence of IL-15 requires IL-15R     
(Fig. S3, available at http://www.jem.org/cgi/content/full/
jem.20071913/DC1). IL-15 may be secreted from cells, and 
a soluble form of IL-15R     (sIL-15R    ) can be released from 
cells (  24, 25  ). Accordingly, we studied the levels of IL-15 and 
    Figure 3.         Release of IL-15 and sIL-15R     proteins and IL-15  –  sIL-
15R     complexes from TLR-stimulated BMDCs.   (A – D)  ELISA  of  super-
natants from stimulated BMDCs. WT, 15KO, R    KO, and mixed 15KO:R   KO 
BMDCs were stimulated with poly I:C for 0 (white bars), 24 (gray bars), 
and 48 h (black bars), after which supernatants were assayed for the pro-
duction of (A) IL-15, (C) IL-15R    , and (D) IL-15  –  sIL-15R     complex  expres-
sion. (B) Supernatants from TLR-stimulated DCs were supplemented with 
0.01% SDS and boiled before ELISA for IL-15 expression. Data are repre-
sentative of three independent experiments.     JEM VOL. 205, May 12, 2008 
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or   IL-15R            /         mice (  Fig. 5 B  ). It was not technically feasible 
to perform ELISA analyses on boiled sera samples and thereby 
quantitate IL-15 protein samples in complexes. However, 
ELISAs revealed that IL-15  –  sIL-15R     complexes are in-
duced only in WT mice (  Fig. 5 C  ). Thus, similar to our fi  nd-
ings with cultured BMDCs, soluble complexes of IL-15 and 
sIL-15R     are induced by TLR stimulation in vivo. 
  diff  erences in IL-15, IL-15R    , and IL-15  –  IL-15R     protein 
levels are likely due to diff  erences in protein production rather 
than diff  erences in recycling or secretion from the cells. 
  Coordinate expression of IL-15 and IL-15R     by DCs 
is required for supporting NK cell activation in vitro 
  Our prior studies indicated that IL-15R     expression on DCs 
is required for NK cell activation (  20  ). As IL-15 signaling in 
splenic DCs has been suggested to support their maturation, 
we fi  rst examined the activation of WT,   IL-15       /        , and   IL-
15R            /         BMDCs (  26  ). Stimulation of BMDCs with poly I:C 
led to modestly reduced levels of IL-12 production and normal 
levels of CD40 and CD86 up-regulation (  Fig. 4, A and B  ).   
Thus, TLR-triggered activation of BMDCs proceeds largely 
normally in the absence of either IL-15 or IL-15R    . 
  To determine whether coordinated expression of IL-15 
and IL-15R     by DCs is required for activating NK cells, we 
stimulated WT,   IL-15       /        ,   IL-15R            /        , or a 1:1 mixture of 
  IL-15       /         and   IL-15R            /         BMDCs with poly I:C and co-
cultured these cells with NK cells. We then assayed NK cell 
activation in these cultures by testing the supernatants of these 
cultures for the production of IFN-     by ELISA. These stud-
ies revealed that IFN-     was secreted in signifi  cant amounts 
only in cultures containing WT BMDCs and not in cultures 
from   IL-15       /        ,   IL-15R            /        , or a mixture of these DCs (  Fig. 
4 C  ). Flow cytometric analyses of these NK cells revealed 
that NK cells from all poly I:C  –  stimulated cultures up-regu-
lated expression of the surface activation marker CD69 (  Fig. 
4 D  ). However, only NK cells co-cultured with WT DCs 
expressed signifi  cant levels of intracellular IFN-     and intra-
cellular granzyme B, indicating that these cells were fully ac-
tivated and armed with cytotoxic granules (  Fig. 4, D and E  ). 
Thus, coordinate expression of IL-15 and IL-15R     in DCs 
is required for NK cell activation, and the failure of mixtures 
of   IL-15       /         and   IL-15R            /         BMDCs to form IL-15  –  IL-15R     
complexes leads to a failure of these cells to fully activate 
NK cells. 
  sIL-15R     and IL-15  –  sIL-15R     complexes are induced 
in the sera of stimulated mice 
  Multiple cell types may be able to respond to TLR ligands 
and elaborate IL-15 and IL-15R    . To determine whether 
the mechanisms that we have elucidated in DCs apply to 
physiological responses in vivo, we studied the expression of 
IL-15, sIL-15R    , and IL-15  –  sIL-15R     complexes in the 
serum of resting and poly I:C  –  stimulated mice by ELISA. 
These experiments revealed that negligible levels of IL-15 
and IL-15R     are present in the sera of resting mice. 24 h af-
ter stimulation with poly I:C, sIL-15R     was detected at sim-
ilarly high levels in the serum of WT and   IL-15       /         mice, but 
not in   IL-15R            /         mice (  Fig. 5 A  ).   Similar results were 
obtained with LPS stimulation (unpublished data). Thus, 
sIL-15R     is physiologically released into the sera from TLR-
stimulated mice. Minimal levels of soluble IL-15 were de-
tected in the serum of poly I:C  –  treated WT mice, and no 
appreciable IL-15 was found in the sera from   IL-15       /         mice 
    Figure 4.         Coordinate expression of IL-15 and IL-15R     is required 
for NK cell activation.   (A) ELISA measurement of IL-12 secretion by 
poly I:C  –  stimulated BMDCs of the indicated genotypes. (B) Flow cytometric 
analysis of DC activation after poly I:C stimulation. Histograms of poly I:C  –
  stimulated DCs (gray-fi  lled histograms) of the indicated genotypes 
indicating surface expression levels of the surface activation markers 
CD40 and CD86. (C) ELISA determination of IFN-     secretion by NK cells 
co-cultured with WT, 15KO, R    KO, or mixed 15KO:R    KO BMDCs. BMDCs 
were treated with PBS or poly I:C for 18 h, after which NK cells were co-
cultured with activated DCs for an additional 6 h. Poly I:C  –  stimulated 
cultures are indicated by black bars, and PBS-stimulated control cultures 
are indicated by white bars. Note that signifi  cant poly I:C  –  induced NK cell 
activation occurs only in the presence of WT DCs. (D and E) Flow cytomet-
ric measurement of NK cell (NK1.1  +  ) activation by poly I:C (p(I:C))   –  stimu-
lated DC  –  NK cell co-cultures. Elevated CD69 surface staining refl  ects 
initial (TLR-dependent, IL-15  –  independent) activation of NK cells. IFN-    
and granzyme B expression by NK cells were performed by intracellular 
staining 6 and 12 h after stimulation, respectively. Numbers indicate the 
percentage of cells in the indicated gate. Note that NK cells express sig-
nifi  cant levels of both IFN-     and granzyme B only when activated by WT 
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ion to cultured BMDCs. Therefore, the cell biology we have 
defi  ned in BMDCs is an accurate refl  ection of physiological 
IL-15  –  sIL-15R     production in vivo. 
  Coordinate expression of IL-15 and IL-15R     
by hematopoeitic cells is required for supporting 
NK cell activation in vivo 
  To determine whether coordinated expression of IL-15 and 
IL-15R     is also required for activating NK cells in vivo, we 
tested the ability of the radiation chimera mice described 
above to activate NK cells. Consistent with our prior studies, 
only mice reconstituted with WT HSCs possessed apprecia-
ble numbers of NK cells (  14, 18, 19  ). To have comparable 
NK cells to assay, we purifi  ed NK cells from   RAG-1       /         mice, 
labeled them with CFSE, and adoptively transferred these la-
beled NK cells into the radiation chimera before stimulating 
the mice with poly I:C (see experimental design,   Fig. 6 A  ).   
Production of IFN-     and granzyme B by the adoptively 
transferred NK cells was assayed by fl  ow cytometry 6 and 12 h 
later, respectively. Importantly, although adoptively trans-
ferred (CFSE  +  ) NK cells were stimulated to express CD69 in 
all poly I:C  –  stimulated mice, NK cells only expressed signifi  -
cant amounts of IFN-     and granzyme B in WT mice (  Fig. 6, 
B and C  ). Thus, the failure of mixtures of   IL-15       /         and   IL-
15R            /         hematopoietic cells to form IL-15  –  sIL-15R     com-
plexes correlates with a failure of these chimeric mice to activate 
NK cells in vivo. 
  Membrane-bound IL-15  –  IL-15R     complexes, rather 
than soluble IL-15  –  sIL-15R     complexes, support 
NK cell activation in vitro 
  The fi  ndings above suggest that membrane-bound IL-15  –  IL-
15R     complexes, soluble IL-15  –  sIL-15R     complexes, or 
both stimulate NK cells. To determine the relative contributions 
of these forms of IL-15  –  IL-15R    , we treated WT,   IL-15       /        , 
  IL-15R            /        , or a 1:1 mixture of   IL-15       /         and   IL-15R            /         
BMDCs with poly I:C, after which supernatants of the four 
types of cultures were exchanged between cultures. NK cells 
were subsequently co-cultured with BMDCs and the ex-
changed supernatants, after which IFN-     production was 
measured by ELISA. These studies revealed that poly I:C  –
  stimulated WT DCs activated NK cells regardless of the type 
of supernatant present, whereas no other DCs or mixtures of 
DCs were able to activate NK cells (  Fig. 7  ).   In contrast, solu-
ble IL-15  –  sIL-15R     complexes found in WT supernatants did 
not augment NK cell activation any better than supernatants 
lacking these complexes (  Fig. 7  ). Moreover, soluble IL-15  –
  sIL-15R     complexes in supernatants of poly I:C  –  stimulated 
WT BMDCs were unable to support NK cell activation in the 
presence of   IL-15       /         or   IL-15R            /         DCs (  Fig. 7  ). Similar re-
sults were obtained with LPS stimulation (unpublished data). 
Thus, membrane-bound IL-15  –  IL-15R     complexes are the 
critical mediators of IL-15  –  mediated NK cell activation. Mean-
while, soluble IL-15  –  sIL-15R     complexes are unable to either 
augment membrane-bound complexes or compensate for the 
lack of membrane-bound complexes. 
  We then asked whether a mixture of   IL-15       /         and   IL-
15R            /         hematopoietic cells could generate IL-15  –  sIL-15R     
complexes in vivo after TLR stimulation. To address this ques-
tion, we fi  rst interbred   IL-15       /         and   IL-15R            /         mice to 
generate double-mutant mice. These double-mutant mice 
phenotypically resemble both   IL-15       /         and   IL-15R            /         
mice, reinforcing the idea that IL-15 and IL-15R     function 
together and do not perform signifi  cant functions indepen-
dently from each other (unpublished data). We irradiated 
these double-mutant mice and reconstituted them with WT, 
  IL-15       /        ,   IL-15R            /        , or a 1:1 mixture of   IL-15       /         and   IL-
15R            /         hematopoietic stem cells (HSCs). 6 wk after recon-
stitution, we stimulated these mice with poly I:C and assayed 
their sera for the presence of IL-15, IL-15R    , and IL-15  –
  sIL-15R     complex proteins after 24 h by ELISA. These ex-
periments revealed that modest levels of IL-15 were induced 
in chimeras reconstituted with WT cell HSCs, but not in 
the other chimera (  Fig. 5 E  ). sIL-15R     was detected at sig-
nifi  cant levels in the sera of both WT and   IL-15       /         HSC-
reconstituted chimera, and at roughly half these levels when 
  IL-15       /         and   IL-15R            /         HSCs were mixed at 1:1 (  Fig. 5 D  ). 
Importantly, IL-15  –  sIL-15R     complexes were detected only 
in the sera of poly I:C  –  stimulated chimera reconstituted with 
WT cells and not in chimera reconstituted with a mixture of 
  IL-15       /         and   IL-15R            /         HSCs (  Fig. 5 F  ). Collectively, 
these results suggest that hematopoietic cells in intact mice 
regulate IL-15 and IL-15R     production in a similar fash-
    Figure 5.         Soluble IL-15, IL-15R      ,   and IL-15  –  sIL-15R     complex 
detection in mouse sera.   ELISA determination of sIL-15R    , IL-15, and 
IL-15 – sIL-15R    proteins in sera from intact (A  –  C, on left) or chimeric 
(D  –  F, on right) mice stimulated with 25   μ  g/g poly I:C or PBS. Sera were col-
lected 24 h after stimulation and IL-15 (B and E), sIL-15R     (A and D), and 
IL-15 – sIL-15R    complex (C and F) protein levels were measured by ELISA. 
Each symbol refl  ects values obtained from individual mice.     JEM VOL. 205, May 12, 2008 
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IL-15  –  IL-15R     complexes and not soluble IL-15  –  sIL-15R     
complexes provide the critical signal for stimulating IFN-     
production by NK cells in vitro and in vivo. 
  IL-15 that emerges from normal DCs does not bind 
to IL-15R     on neighboring DCs 
  Free IL-15 has been reported in certain pathological condi-
tions, and soluble recombinant IL-15 can be added to cells and 
bind to IL-15R    . Hence, an additional question is whether 
IL-15  –  IL-15R     complexes that emerge onto cell surfaces 
dissociate at an appreciable rate to release free soluble IL-15 
that can bind to IL-15R     on other cells. To address this ques-
tion, we stimulated 1:1 mixtures of congenic CD45.1  +   WT 
DCs and either CD45.2  +   (CD45.1       )   IL-15       /         (15KO) DCs 
or CD45.2  +   (CD45.1       )   IL-15R            /         (R    KO) DCs with 
poly I:C. Cell surface expression levels of IL-15 and IL-15R     
were examined after 24 h. In mixtures of WT and   IL-15R            /         
DCs, both IL-15 and IL-15R     proteins are readily induced 
by poly I:C on the surface of WT (CD45.1  +  ) cells, whereas 
neither protein is seen on the surface of  IL-15R            /         (CD45.1       ) 
cells (  Fig. 8 A  , panels 1  –  4, and Fig. S5, which is available 
at http://www.jem.org/cgi/content/full/jem.20071913/DC1).  
In mixtures of WT (CD45.1  +  ) and   IL-15       /         (CD45.1       ) 
DCs, IL-15R     protein is induced to identical levels on the 
surfaces of both types of cells by poly I:C (  Fig. 8 A  , panels 7 
and 8, and Fig. S5). Remarkably, IL-15 protein was induced 
only on the surface of WT (CD45.1  +  ) cells and was not found 
on   IL-15       /         (CD45.1       ) cells, despite the fact that   IL-15       /         
cells express identical levels of surface IL-15R     (  Fig. 8 A  , 
panels 5 and 6, and Fig. S5). Thus, IL-15 that emerges from 
WT cells is not released in appreciable amounts to bind to 
contiguous, neighboring cells. 
  To further examine whether IL-15  –  IL-15R     complexes 
on the surface of DCs might release free soluble IL-15 pro-
tein, even if transiently, we tested the ability of an anti  –  IL-15 
  Membrane-bound IL-15  –  IL-15R     complexes, rather than 
soluble IL-15  –  sIL-15R     complexes, support NK cell 
activation ex vivo 
  To determine whether membrane-bound or soluble IL-15  –
  sIL-15R     complexes support NK cell activation ex vivo, we 
tested whether serum containing these complexes could sup-
port NK cell activation. We generated radiation chimera in 
which   IL-15       /       IL-15R            /         double-mutant mice were re-
constituted with WT,   IL-15       /        ,   IL-15R            /        , or a 1:1 mix-
ture of  IL-15       /         and  IL-15R            /         HSCs. 24 h after stimulation 
with poly I:C, IL-15  –  sIL-15R     complexes were present only 
in the sera of WT HSC  –  reconstituted chimera, consistent 
with our fi  ndings above (  Fig. 5  ). We incubated this undi-
luted serum with purifi  ed NK cells in vitro for 6 h and as-
sayed the NK cells for expression of CD69 and intracellular 
IFN-    . These studies showed that serum from poly I:C  –
  stimulated mice caused NK cells to express CD69 but did 
not induce IFN-     expression (Fig. S4, available at http://
www.jem.org/cgi/content/full/jem.20071913/DC1). Re-
inforcing our fi  ndings above with supernatants from activated 
BMDCs (  Fig. 7  ), these studies indicate that membrane-bound 
    Figure 6.         Full activation of NK cells requires coordinate expression 
of IL-15 and IL-15R     in vivo.   (A) Experimental design. Bone marrow 
HSCs of the indicated genotypes were used to reconstitute irradiated   IL-
15     /        IL-15R       /       double-mutant  (15KO/R   KO DKO) mice. After 6 wk, NK 
cells from   RAG-1     /       (RAG-1 KO) mice were CFSE labeled and transferred 
into the chimera. Mice were then activated with 25   μ  g/g poly I:C and stud-
ied for NK cell activation. (B and C) Flow cytometric analyses of (B) surface 
CD69 expression and intracellular IFN-     after 6 h and (C) CD69 and intra-
cellular granzyme B expression after 12 h. Note robust NK cell expression 
of intracellular IFN-     and granzyme B in WT HSC  –  reconstituted chimera, 
but not in chimera reconstituted with 15KO, R    KO, or mixed 15KO/R   KO 
HSCs. Results are representative of two independent experiments.     
    Figure 7.         Soluble IL-15 complexed with sIL-15R     fails to activate 
NK cells.   Activation of IFN-     secretion by NK cells co-cultured with vari-
ous combinations of poly I:C  –  stimulated BMDCs and supernatants from 
these BMDCs. BMDCs from various genotypes (indicated along the x axis 
of graph) were activated with poly I:C and then supplemented with super-
natants exchanged from similarly activated BMDCs. Genotypes of DCs 
from which supernatants were derived are indicated by individual columns 
(gray, WT; white, 15KO; black, R    KO; checkered, mixture of 15KO and 
R    KO). ELISA quantitation of NK cell IFN-     secretion is indicated on the 
y axis. Note that WT DCs activate NK cells regardless of the type of superna-
tant added. Note also that WT DC  –  derived supernatants containing IL-15  –
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cent studies have suggested that both IL-15 and DCs are criti-
cal for NK cell activation in vivo (  20, 22  ). However, these 
studies leave open the possibility that IL-15 and DCs might in-
dependently support NK cell activation in vivo. For example, 
IL-15 might be produced by macrophages to stimulate DCs to 
activate NK cells in vivo. To more directly investigate whether 
IL-15R     expression by DCs mediates NK cell activation 
in vivo, we reconstituted irradiated   IL-15       /           IL-15R            /         dou-
ble-mutant mice with a 1:1 mixture of HSCs from CD11c  –
  diphtheria toxin (DT) receptor (CD11c-DTR) transgenic 
mice and HSCs from either WT or   IL-15R            /         mice. After 
hematopoietic reconstitution, DT was injected into the chi-
mera to transiently eliminate DCs. 24 h later, mice were in-
jected with poly I:C. Finally, 6 h later, the status of CD11cHi 
DCs and the activation of NK cells were studied by fl  ow cy-
tometry (see experimental scheme,   Fig. 9 A  ).   These experi-
ments revealed that DT eliminated approximately half of the 
CD11cHi DCs in chimera reconstituted with a 1:1 mixture of 
CD11c-DTR and other HSCs (  Fig. 9 B  ). The remaining CD-
11cHi DCs expressed IL-15R     after poly I:C stimulation in 
chimera reconstituted with WT HSCs and did not express 
IL-15R     in chimera reconstituted with   IL-15R            /         HSCs 
(  Fig. 9 C  ). Thus, this experiment created chimeric mice in 
which   IL-15R            /         DCs could be compared directly to IL-
15R      +   DCs in their ability to activate NK cells. 
  Turning to NK cell activation in these chimera, we found 
that NK cells up-regulated CD69 in all poly I:C  –  stimulated 
mice, so both WT and   IL-15R            /         DCs support this initial 
step of NK cell activation (  Fig. 9 D  ). In contrast, WT DCs 
stimulated much greater numbers of NK cells to produce IFN-     
when compared with   IL-15R            /         DCs (  Fig. 9 D  , compare 
second to third columns). Mice bearing a mixture of CD11c-
DTR and   IL-15R            /         DCs also supported NK cell produc-
tion of IFN-     in the absence of DT (  Fig. 9 D  , compare third 
to fourth columns). Parallel experiments performed with chi-
meric mice reconstituted with mixtures of CD11c-DTR 
and either WT or   IL-15       /         HSCs revealed similar results, i.e., 
  IL-15       /         DCs are also unable to activate NK cells in vivo 
(  Fig. 9 E  ). Therefore, DCs must express both IL-15 and IL-
15R     to activate NK cells under physiological conditions. 
    DISCUSSION   
  Our current studies reveal a novel cell biological mecha-
nism by which IL-15 is coexpressed with IL-15R     in DCs 
after TLR stimulation and binds IL-15 within the ER  –  Golgi 
complex. Plasma membrane-bound IL-15  –  IL-15R     com-
plexes are highly stable complexes that do not release appre-
ciable amounts of free IL-15 to neighboring IL-15R     –  bearing 
cells. These membrane-bound complexes trans present IL-15 
to responsive cells during cell  –  cell contact, mediating the 
critical stimulatory signal to NK cells. Soluble IL-15  –  sIL-
15R     complexes are released from the cell surface, but these 
complexes fail to provide agonistic signals. We have coupled 
these cell biological studies with in vivo studies that have 
confi  rmed the physiological validity of our experiments with 
cultured DCs. Finally, we have demonstrated that IL-15R     
monoclonal antibody that binds only free IL-15 to compete 
with the formation of membrane IL-15  –  IL-15R     complexes 
on the surface of poly I:C  –  stimulated DCs. We incubated 
progressively higher doses of anti  –  IL-15 antibody with WT 
DCs at the same time that they were stimulated with poly I:C 
and measured the amount of membrane-bound IL-15 after 
24 h. These experiments revealed that the number of DCs ex-
pressing surface IL-15 and the intensity of surface staining were 
unchanged by doses of anti  –  IL-15 antibody of up to 25   μ  g/ml 
(  Fig. 8 B  ). Hence, negligible amounts of membrane-bound 
IL-15 are released by membrane IL-15R    . Therefore, physio-
logically induced IL-15  –  IL-15R     complexes on DC surfaces 
do not dissociate at appreciable rates. 
  IL-15R     expression on DCs is essential for NK cell activation 
in vivo 
  Our recent work showed that IL-15R     expression by DCs is 
essential for DC-mediated NK cell activation in vitro, and re-
    Figure 8.         IL-15 that emerges from normal DCs does not bind to 
IL-15R     on neighboring DCs.   (A) Flow cytometric analyses of surface 
IL-15 and IL-15R     expression in mixed DC cultures. 1:1 mixtures of con-
genic WT (CD45.1  +  ) and IL-15R       /     BMDCs  (WT:R   KO; panels 1  –  4) or 1:1 
mixtures of congenic WT (CD45.1  +  ) and IL-15     /     BMDCs (WT:15KO; pan-
els 5  –  8) were stimulated in vitro with PBS or poly I:C for 24 h. Surface 
expression of IL-15 and IL-15R     (and CD45.1) proteins was then analyzed 
by fl  ow cytometry. Note that poly I:C  –  stimulated IL-15     /     BMDCs  express 
normal levels of IL-15R     (panel 8), but fail to capture or bind IL-15 even 
though virtually all of their neighboring WT DCs possess elevated levels of 
IL-15 in the same cultures (panel 6). (B) Flow cytometric analysis of sur-
face IL-15 expression on normal BMDCs stimulated with poly I:C in the 
presence of the indicated doses of anti  –  IL-15 antibody. Note that WT 
BMDCs induce similar amounts of surface IL-15 protein (gray, fi  lled histo-
grams) regardless of the amount of inhibitor anti  –  IL-15 antibody in the 
cultures. Numbers indicate the percentage of cells whose fl  uorescence 
intensity lies beyond the unstimulated control cells. All data are represen-
tative of at least two independent experiments.     JEM VOL. 205, May 12, 2008 
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expression specifi  cally on DCs plays an essential role in sup-
porting NK cell activation in mice. As membrane-bound IL-
15R      –  IL-15 complexes on DCs appear to play a dominant 
role in supporting NK cell activation in vivo, these studies 
highlight the notion that cytokine signals may be delivered 
by specifi  c cell types in cell contact  –  dependent fashion. 
  IL-15R    , a chaperone for IL-15 
  We have found that EndoH-sensitive forms of IL-15 are 
bound to IL-15R     in LPS-stimulated DCs, and that IL-15  –
  IL-15R     complexes can be found in brefeldin A  –  treated but 
not cycloheximide-treated cells. Considered together with 
our discovery that DCs must express IL-15R     to secrete IL-
15, it is likely that IL-15R     binds to IL-15 and stabilizes this 
protein in the ER and/or Golgi apparatus. Such complexes 
probably prevent free IL-15 from undergoing ER-associated 
protein degradation, a well-established process by which 
  “  misfolded  ”   proteins in the ER are proteolyzed in ubiquitin- 
and proteosome-dependent processes (  27  ). Recycling and 
trans presentation of these membrane-bound complexes may 
then stimulate responding cells (  14  ). Hence, our results sug-
gest that IL-15R     functions both as an intracellular chaper-
one for IL-15 as well as an extracellular scaff  old that presents 
IL-15 to responsive cells. 
  We have shown that IL-15  –  IL-15R     complexes that 
emerge onto the surface of DCs fail to release soluble IL-15 
to neighboring IL-15R      –  expressing DCs. These surprising 
observations suggest that IL-15  –  IL-15R     complexes on DC 
surfaces are highly stable, a fi  nding consistent with the high 
affi   nity of IL-15R     for IL-15 (    5   ×   10      11   M) (  8  ). Thus, 
although heterologous IL-15 can be added to IL-15R      –
  expressing cells, form cell surface complexes, and stimulate 
IL-15  –  dependent responses, the physiological production and 
trans presentation of IL-15 by DCs appears to predominantly 
involve IL-15  –  IL-15R     complexes that form intracellularly 
during biosynthesis and remain intact for prolonged periods 
(e.g., 24 h) (  17  ). 
  Preassembly of IL-15  –  IL-15R     protein complexes in DCs 
explains a requirement for coordinate expression of IL-15 
and IL-15R     to support NK cell activation 
  Our fi  nding that IL-15  –  IL-15R     complexes are preassem-
bled within DCs provides an explanation for why coordinate 
expression of these molecules is required for NK cell activation 
    Figure 9.         DC-specifi  c expression of IL-15R     is required for NK 
cell activation in vivo.   (A) Experimental scheme. The indicated mixtures 
of HSCs were used to reconstitute double-mutant 15KO/R    KO mice. After 
6 wk, chimeric mice were treated with DT and then activated with poly I:C. 
(B) Flow cytometric quantitation of splenic DCs (CD11c  HI   I-Ab +  ) after DT 
treatment. The percentage of splenic DCs from the chimera reconstituted 
with the indicated HSCs is shown. (C) Selective loss of CD11c-DTR DCs in 
mixed radiation chimera. Surface expression of IL-15R     after DT treat-
ment and poly I:C was analyzed by fl  ow cytometry. Note that elimination 
of CD11c-DTR DCs by DT treatment leaves elevated surface expression of 
IL-15R     on the remaining WT DCs in CD11-DTR:WT mixed chimera (mid-
dle), whereas DT treatment of CD11c-DTR:R    KO mixed chimera leaves 
residual   IL-15R       /       DCs (right). Splenic DCs from PBS-treated mice is 
shown as a control (left). (D) NK cells require IL-15R     expression on DCs 
for full activation in vivo. Splenic NK cells from the mice above were ana-
lyzed for CD69 and IFN-     expression by fl  ow cytometry. Note that chi-
meras containing WT DCs (second column) or CD11c-DTR DCs (no DT 
treatment, fourth column) but not chimera containing R    KO DCs (third 
column) support NK cell production of IFN-     (top panels). Note that mice 
containing signifi  cant residual DCs after DT treatment induce NK cell 
expression of CD69 after poly I:C (columns 2  –  4). WT HSC  –  reconstituted 
chimera treated with PBS (fi  rst column) are included as a control. Results 
are representative of two independent experiments, with eight mice used 
for each experiment. (E) NK cells require IL-15 expression on DCs for full 
activation in vivo. Chimera reconstituted with a 1:1 mixture of CD11-DTR 
HSCs with either WT HSCs (left) or   IL-15     /       HSCs (right) were treated as 
in A and D above, and fl  ow cytometric analyses of NK cell expression of 
CD69 and IFN-     are  shown.   
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  sIL-15R     complex and the membrane-bound IL-15  –  IL-15R     
complex. Alternatively, membrane-bound IL-15  –  IL-15R     
complexes may possess a competitive advantage over soluble 
IL-15  –  sIL-15R     complexes due to the increased local con-
centration or valency of membrane-bound complexes during 
cell  –  cell contact. 
  The failure of endogenous soluble IL-15  –  sIL-15R     com-
plexes to activate NK cells can also be contrasted with recent 
studies indicating that certain cytokine-specifi  c  antibodies 
can form complexes with their cognate cytokines, stabilize 
cytokines, and amplify the immunological eff  ects of these 
cytokines (  29  –  31  ). There are multiple diff  erences between 
antibody  –  cytokine complexes and receptor  –  cytokine com-
plexes. For example, diff  erent anti  –  IL-15 antibodies or forms 
of IL-15R     may interfere with IL-15 binding to IL-2/15R     
and     c receptors. In addition, antibodies, but not soluble cy-
tokine receptors, can also bind to Fc receptors on multiple 
cells. Recent structural studies of IL-15 and IL-15R     pro-
teins have revealed important insights into how these proteins 
interact and should facilitate future investigations into how 
such receptor –  cytokine complexes diff  er from antibody –  cyto-
kine complexes (  32  ). Combining these biochemical insights 
with the divergent biological properties of these complexes 
should facilitate future attempts to engineer these proteins for 
therapeutic benefi  t (  33, 34  ). 
  DCs require IL-15R     to trans present IL-15 to NK cells 
during NK cell activation 
  We have used mixed radiation chimera to selectively unveil 
the role of IL-15R     expression by DCs during NK cell acti-
vation in vivo. Our fi  ndings extend our prior work that IL-
15R     on BMDCs is critical for activating NK cells in vitro 
(  20  ). Our current fi  ndings are also consistent with a recent 
study using both IL-15      /      mice and CD11c-DTR mice to 
show that both IL-15 and DCs are required for NK cell acti-
vation in vivo (  22  ). By using mixed radiation chimera gener-
ated from both   IL-15R            /         and CD11c-DTR HSCs, we 
have extended the prior work to show that IL-15R     expres-
sion specifi  cally on DCs mediates NK cell activation in vivo. 
Further elucidation of these interactions should be facilitated 
by the generation of mice bearing lineage-specifi  c deletions 
of IL-15 or IL-15R    . Considered together with our data 
showing that DCs trans present IL-15 via cell  –  cell contact, 
and with recent work showing the localization of NK cells to 
lymphoid structures, a model of NK cell activation emerges 
in which NK cells are recruited to DCs and receive critical 
IL-15  –  IL-15R      –  dependent activation signals during DC  –
  NK cell contact (  35, 36  ). In this regard, DC activation of NK 
cells broadly resembles DC activation of naive T cells, during 
which an immunological synapse constitutes a sophisticated 
cell contact  –  dependent activation mechanism. Indeed, direct 
evidence for a DC  –  NK cell synapse directing IL-15 signaling 
to NK cells has recently been reported (  37  ). 
  Recent structural studies have revived the notion that 
IL-2R     may trans present IL-2 (  38  –  40  ). Although IL-2 sig-
nals clearly perform distinct biological functions from IL-15 
in vitro and in vivo. Coordinate expression of IL-15 and IL-
15R     by DCs is required for the formation of IL-15  –  IL-
15R     complexes and the activation of NK cells in vitro and 
in vivo after TLR stimulation. This result parallels prior fi  nd-
ings that coordinate expression of these molecules is neces-
sary to perform IL-15  –  dependent homeostatic functions in 
resting mice (  18, 19  ). Hence, the cell biology of IL-15 and 
IL-15R     interactions during infl   ammatory conditions re-
sembles the homeostatic condition. 
  In addition to identifying intracellular complexes of IL-
15 and IL-15R    , we have identifi  ed soluble extracellular IL-
15  –  sIL-15R     complexes that are released from DCs after 
TLR stimulation. A prior study described the presence of 
soluble IL-15R     in the serum of resting mice, and proposed 
that IL-15R     could be proteolytically cleaved from the cell 
surface (  24  ). Our current experiments extend and contrast 
with the prior results in two respects. First, we fi  nd that the 
production and release of soluble sIL-15R     is induced by 
TLR stimulation, rather than being constitutively present at 
high levels (e.g., 40 ng/ml) in resting C57BL/6J strain mice 
(  24  ). Second, we fi  nd that the majority of soluble IL-15R     
is complexed with IL-15. Therefore, although free IL-15 is 
not released from DCs, soluble IL-15  –  sIL-15R     complexes, 
which may represent IL-15 bound to a proteolytic product of 
IL-15R    , are released into solution. 
  Our results with both cultured DC supernatants and mouse 
sera indicate that membrane-bound IL-15  –  IL-15R     com-
plexes on DCs and not soluble IL-15  –  sIL-15R     complexes 
support NK cell production of IFN-     and granzyme B. 
Although soluble IL-15  –  sIL-15R     complexes might per-
form other functions, this important fi  nding suggests that 
trans presentation of IL-15 requires cell  –  cell contact between 
IL-15  –  presenting and IL-15  –  responsive cells. The cell contact  –
  dependent nature of IL-15 trans presentation also implies that 
IL-15 signals may be delivered in the context of other signals 
between the two cells, akin to antigen presentation between 
DCs and T cells. Finally, our fi  ndings imply that IL-15 signals 
are delivered via direct cell  –  cell contact rather than via soluble 
proteins. Hence, cytokine-mediated survival, growth, and 
activation signals may be delivered by specifi  c cell types and 
in specifi  c locations. 
  Although the physiological functions of soluble IL-15  –
  sIL-15R     complexes are unclear, it is important to note that 
these complexes are neither agonistic nor antagonistic in our 
DC  –  NK cell co-culture assays (  Fig. 7 A  ). In this regard, non-
agonsitic soluble IL-15  –  sIL-15R     complexes contrast with 
agonistic soluble IL-6  –  IL-6R complexes (  28  ). This observation 
provides important clues about their function. If soluble com-
plexes bound to IL-2/15R    /    c receptors as well as mem-
brane-bound complexes, one might expect them to display 
either agonist or antagonist activities (via competitive in-
hibition). Thus, soluble IL-15  –  sIL-15R     complexes may not 
bind well to cell surface IL-2/15R     receptors on cell surfaces 
under physiological circumstances. This failure of IL-15  –  sIL-
15R     complexes to bind IL-2/15R     receptors could be due 
to diff  erences between the structures of the soluble IL-15  –JEM VOL. 205, May 12, 2008 
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  For DC-mediated activation of NK cells in vitro, 2   ×   10  5  /ml BMDCs 
were cultured for 24 h in the presence of 1   μ  g/ml LPS or 25   μ  g/ml poly I:C, 
followed by incubation with 10  5  /ml NK cells as described previously (  20  ). 
  Detection of endogenous IL-15 and IL-15R     proteins.     For ELISA-
based quantitation of proteins, IL-15R     was quantifi  ed using the Duo-set 
kit (R  &  D Systems) according to the manufacturer  ’  s instructions. IL-15 was 
quantifi  ed by using anti  –  IL-15 AIO3 antibody (eBioscience) as a capture re-
agent and biotinylated BAF447 antibody (R  &  D Systems) as the detection 
reagent. For IL-15  –  IL-15R     complex detection, anti  –  IL-15 AF447 anti-
body (R  &  D Systems) was used as the capture antibody and anti  –  IL-15R     
(from the Duo-set kit) as the detection antibody. For ELISA-based analyses 
of intracellular IL-15 and IL-15R     proteins, 5  –  10   ×   10  6   BMDCs per condi-
tion were lysed in NP-40 lysate buff  er (50 mM Hepes, 120 mM NaCl, 1 mM 
EDTA, 0.1% NP-40, and protease inhibitor cocktail [Roche]). IFN-     and 
IL-12 were quantifi  ed using a commercial assay kit according to the manu-
facturer  ’  s instructions (BD Biosciences). 
  For immunoblotting detection of intracellular IL-15 and IL-15R    , 5  –
  10   ×   10  6   BMDCs were stimulated for 12 or 24 h with 0.1   μ  g/ml LPS 
washed in PBS and lysed in NP-40 or RIPA lysis buff  er (0.5% SDS, 0.1% 
deoxycholic acid and 1% NP-40 in PBS, 150 mM NaCl, 50 mM Tris, pH 
7.5, 1 mM NaVO4, 1 mM NaF, 1 mM PMSF, and protease inhibitors 
[Roche]), cleared by centrifugation (14,000   g   for 20 min at 4  °  C), and 
immunoprecipitated with a mixture of anti  –  IL-15R     AF 551 (R  &  D Sys-
tems) and anti  –  IL-15R     N19 (Santa Cruz Biotechnology, Inc.) with a 
mixture of protein A  –   and protein G  –  coupled Sepharose beads. Immuno-
precipitates were then washed in lysis buff  er and subjected to SDS-PAGE. 
Immunoblotting of transferred proteins was performed with either rat anti  –
  IL-15 antibody (Amgen) and goat anti  –  rat IgG horseradish peroxidase (Jack-
son ImmunoResearch Laboratories) or biotin-conjugated anti  –  IL-15R     
antibody BAF 551 (R  &  D Systems) and streptavidin  –  horseradish peroxidase 
(BD Biosciences). EndoH sensitivity assays were performed by treating 
immunoprecipitates with EndoH per the manufacturer  ’  s instructions (New 
England Biolabs, Inc.). 
  Surface IL-15 expression was detected using biotinylated anti  –  IL-15 an-
tibody (PeproTech). IL-15R     expression on cell surfaces was detected by 
using biotinylated anti  –  IL-15R     antibody BAF551 (R  &  D Systems) as de-
scribed previously (  15  ). IFN-     and granzyme B production by NK cells was 
determined by intracellular cytokine staining as described previously (Caltag 
and eBioscience) (  12  ). Cell surface expression of NK1.1, CD69, CD40, 
CD86, CD11b, CD11c, and I-A  b   was performed using commercial anti-
bodies (BD Biosciences). Cells were analyzed with an LSR II cytometer 
(Becton Dickinson) and FloJo software. 
  Online supplemental material.     Fig. S1 shows the detection of IL-15 and 
IL-15R     proteins and the IL-15  –  IL-15R     complex. In Fig. S2, brefeldin A 
treatment blocks the emergence of IL-15R     onto the surface of cells or into 
the supernatants of DCs. Fig. S3 shows the expression of IL-15 and sIL-
15R     proteins on the cell surface of TLR-stimulated BMDCs. Fig. S4 
shows that soluble IL-15 complexed with sIL-15R     fails to activate NK cells 
ex vivo. In Fig. S5, IL-15 that emerges from normal DCs does not bind to 
IL-15R     on neighboring DCs. The online supplemental material is available 
at http://www.jem.org/cgi/content/full/jem.20071913/DC1. 
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signals in vivo, and although IL-2R     has not shown the ca-
pacity to bind and trans present IL-2 in vivo, directed cyto-
kine presentation may nevertheless be a feature of IL-15, IL-2, 
and perhaps other cytokines (  7, 10, 38, 41, 42  ). This mode of 
cell contact –  dependent delivery of cytokine signals would greatly 
restrict the cells that receive cytokine signals. Finally, given 
the rapidity with which memory CD8  +   T cells are reactivated 
in vivo, the requirement for DCs to reactivate memory CD8  +   
T cells, the selective expression of IL-2/15R     receptors by 
these cells, and the IL-15 dependence of these cells, it is pos-
sible that memory CD8  +   T cell reactivation involves a similar 
IL-15  –  dependent activation event mediated by DCs (  43  ). 
  In summary, we have shown that IL-15 and IL-15R     are 
preformed as complexes in DCs in response to TLR stimula-
tion. IL-15  –  IL-15R     complexes progress to the DC surface 
where they deliver critical activating signals to NK cells dur-
ing cell  –  cell contact. IL-15  –  IL-15R     complexes that are 
cleaved from the surface of DCs may be byproducts of a ter-
mination mechanism for this potent stimulus. This novel 
series of cell biological events refi  nes our understanding of 
IL-15R      –  mediated trans presentation, and highlights how 
the immune system delivers cytokine signals in a highly regu-
lated and cell type  –   and geographically restricted fashion. 
  MATERIALS AND METHODS 
  Mice, radiation chimera, adoptive transfers, and in vivo DC ablation.   
    IL-15R            /         (R    KO) mice were described previously (  10  ). All strains were 
backbred to a C57B1/6J background for at least 12 generations.   IL-15       /         
(15KO) and   RAG-1       /         mice on a C57BL/6J background were purchased 
from Taconic Laboratories. CD11c-DTR transgenic mice were purchased 
from The Jackson Laboratory (  44  ). Double-mutant   IL-15       /       IL-15R            /         
(15KO/R    KO) mice were generated by interbreeding in our facility. Radi-
ation bone marrow chimeras were produced as described previously, except 
that mixed 15KO:R    KO, CD11c-DTR:WT, and CD11c-DTR:R    KO 
radiation chimera were generated by using mixtures (1:1) of bone marrow 
cells from congenic donors of the indicated genotypes of mice (  18  ). All mice 
were used between the ages of 6 and 12 wk of age. All animal experiments 
were approved by the Institutional Animal Care and Use Committee of the 
University of California, San Francisco. 
  For in vivo stimulation experiments, mice were injected intraperitone-
ally with 10 g/kg LPS (Sigma-Aldrich) or 25 g/kg poly I:C (GE Healthcare). 
For adoptive transfer experiments, NK cells were purifi  ed from the spleens 
of   RAG-1       /         mice by adherence and magnetic bead depletion of myeloid 
cells, and in some experiments, labeled with CFSE before intravenous injec-
tion into recipient mice as described previously (  18  ). In vivo depletion of 
CD11c       DTR  +   DCs was performed using a single injection of 2  –  4   μ  g/kg 
body weight of DT (EMD) (  44  ). 
  In vitro DC preparations and assays.     BMDCs were generated in culture 
as described previously (  18  ). The purity of BMDC cultures was checked by 
analyzing an aliquot of each culture for surface expression of CD11c and 
CD11b by fl  ow cytometry (BD Biosciences). Splenic DCs were enriched by 
digesting spleens with 2.5 mg/ml collagenase B (Boehringer Mannheim) 
and 0.3 mg/ml DNase I (Sigma-Aldrich), followed by isolation on percoll 
gradients as described previously (  18  ). TLR stimulation of DCs was per-
formed with either 1   μ  g/ml LPS or 25   μ  g/ml poly I:C. To inhibit protein 
secretion, BMDCs were treated with Golgi Plug (brefeldin A; BD Biosci-
ences) during the LPS stimulation per the manufacturer  ’  s instructions. To 
inhibit protein synthesis, BMDCs were treated with 10   μ  g/ml cyclohexi-
mide during LPS stimulation. 1224 IL-15R     CHAPERONES IL-15 TO DENDRITIC CELL MEMBRANES | Mortier et al.
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